AtriCure
ATRC
198 hedge funds and large institutions have $2.45B invested in AtriCure in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 68 increasing their positions, 58 reducing their positions, and 23 closing their positions.
74% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 23
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
44% more capital invested
Capital invested by funds: $1.7B → $2.45B (+$749M)
29% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $818K
17% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 58
8% more funds holding
Funds holding: 183 → 198 (+15)
3.01% more ownership
Funds ownership: 94.74% → 97.75% (+3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$44.3M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$24.1M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$19.3M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$17.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$138M |
| 2 |
Renaissance Technologies
New York
|
-$23.8M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$16.5M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$14.6M |
| 5 |
PA
Perceptive Advisors
New York
|
-$8.64M |
ATRC Hedge Fund Activity: Q4 2020 in Review
198 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2020, worth a combined $2.45B — up 44% from $1.7B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ATRC positions and 23 closed out — a net gain of 17 holders — while 68 added to existing stakes and 58 trimmed.
The largest buyer was Credit Suisse, adding an estimated $44.3M. The largest seller was Fidelity Investments, cutting an estimated $138M.
- 198 institutional investors held AtriCure (ATRC) as of Q4 2020, up from 183 in Q3 2020.
- Funds reported $2.45B of AtriCure stock for Q4 2020, up 44% quarter-over-quarter.
- 40 funds opened new AtriCure positions in Q4 2020 and 23 closed out, a net change of +17 holders.
- The largest AtriCure buyer in Q4 2020 was Credit Suisse, an estimated $44.3M added.
- The largest AtriCure seller in Q4 2020 was Fidelity Investments, an estimated $138M sold.
Based on aggregated 13F filings for Q4 2020.